Effient Tablet, Coated
Product Images NDC 0713-0882

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Effient (NDC 0713-0882). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cosette Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Effient 01)

A line graph comparing the percentage of patients with non-CABG-related TIMI major or minor bleeding events over time between Effient and Clopidogrel. The x-axis shows days from randomization up to 450 days, and the y-axis shows the percentage of bleeding events. Effient consistently shows a higher percentage of events than Clopidogrel. The graph includes risk numbers for both drugs at various time points and an inset graph showing data for the first 7 days.*

FDA Label Image

Chemical Structure (Effient 02)

Chemical structure of Prasugrel Hydrochloride, the active ingredient in Effient tablets. The diagram shows the molecular arrangement, including the cyclopropyl group, fluorophenyl, thienopyridine moiety, and the hydrochloride component.*

FDA Label Image

Figure 2 (Effient 03)

A line graph showing inhibition of platelet aggregation (%) over time (hours) for Effient (Prasugrel Hydrochloride). The graph plots mean ± standard deviation values measured with 20 μM ADP, indicating rapid onset within 2 hours followed by a sustained inhibition effect up to 24 hours.*

FDA Label Image

Figure 3 (Effient 04)

This image contains two line graphs comparing cardiovascular death, nonfatal myocardial infarction (MI), or nonfatal stroke percentages over days from randomization between Effient and Clopidogrel. The top graph is for UA/NSTEMI patients, showing lower event rates with Effient. The bottom graph is for STEMI patients, similarly showing lower event rates with Effient. Both graphs include p-values indicating statistical significance.*

FDA Label Image

Figure 4 (Effient 05)

A forest plot chart displaying baseline characteristics and corresponding percent events comparing Effient versus Clopidogrel in various subgroups. The plot includes hazard ratios with confidence intervals, illustrating the relative event rates for subpopulations such as age groups, gender, body weight, region, diabetes status, prior medical history, time from symptom onset, stent type, and inhibitor use.*

FDA Label Image

Figure 5 (Effient 06)

A forest plot chart comparing the percent events between Effient and Clopidogrel across various baseline characteristics such as age, gender, body weight, region, diabetes status, metabolic syndrome, previous medical conditions, and treatment specifics. The chart shows hazard ratios with confidence intervals, visually illustrating the relative performance of Effient versus Clopidogrel in the context of these patient subgroups.*

FDA Label Image

Principal Display Panel (5 mg Tablet Bottle Label)

Effient 5 mg coated tablets packaging label by Cosette Pharmaceuticals, Inc. The label indicates a bottle of 30 tablets with NDC 0713-0881-30. It includes usage instructions, storage conditions, and warnings, with a yellow tablet image embossed with '5' shown on the label.*

FDA Label Image

Principal Display Panel (10 mg Tablet Bottle Label)

Effient 10 mg (prasugrel) coated tablets label for oral use, containing 30 tablets. The label includes directions for storage and dispensing, emphasizing keeping the container closed and not removing the desiccant. Marketed by Cosette Pharmaceuticals, Inc. The label displays the NDC 0713-0882-30 and features a tablet image embossed with the number 10.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.